Company / Book Value per Share
Vistagen Therapeutics, Inc. Book Value per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
-$0.134
FY2021
5-year range
-$1.909 / $0.121
FY2017-FY2021
Trend
-211.3%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed -211% YoY in FY2021, a notable deviation from the 5-year average annual change of -1397%.
Based on SEC 10-K filings.
-$0.134 in FY2021.
Improved from -$1.909 to -$0.134 over the past 4 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, book value per share decreased 211.3% year-over-year.
- Peak book value per share was recorded in FY2018.
- Lowest book value per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$0.134 | -211.3% |
| FY2018 | $0.121 | +106.3% |
| FY2017 | -$1.909 | -175.3% |
| FY2014 | -$0.693 | +76.6% |
| FY2012 | -$2.961 | -6782.0% |
| FY2011 | -$0.043 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026